BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:26TH PHARMACOVIGILANCE 2021\n\n“Ensuring safer drugs to market
  by analyzing latest developments in pharmacovigilance\, drug safety and 
 risk management”\n\n11th November 2021\, Virtual Conference (Time Zone – 
 IST)\n\nVirtue insight’s 26th Pharmacovigilance Conference is more than a
  traditional conference. It is a unique opportunity to learn about the la
 test trends\, to engage with renowned experts\, and to personally develop
  as a healthcare professional. Take this opportunity to learn from regula
 tors and leading experts and discover what the challenges and opportuniti
 es will be in the field of Pharmacovigilance in 2021. Do not miss out on 
 these exciting discussions. Join us virtually to discover and learn from 
 the experts who will be joining us on 11th November 2021.\n\nDELEGATE REG
 ISTRATION:\n\nE-mail - kavitha@virtueinsight.co.in or Call M: +91 9361957
 193 or +91 44 24762472\n\nPlease note that this is a PAID event and NOT A
  FREE event (no complimentary passes available). Any invite\, email or ti
 ckets issued mentioning it as a free pass or free ticket to this event th
 rough any third party site will strictly not be accepted by the organizer
 .\n\nEarly Bird Price (Valid Till 27th September 2021)\n\n(INR 6\,000 + G
 ST (18%) per delegate)\n\nStandard Price (Valid From 28th September 2021)
 \n\n(INR 8\,000 + GST (18%) per delegate)\n\nConference Sponsor\, Exhibit
 ion Stall &amp\; Paid Speaker Slot - Please email your interest and queri
 es to kavitha@virtueinsight.co.in\n\nKEY SPEAKERS:\n\n\nK BANGARURAJAN\, 
 Adviser\, CDSCO (New Delhi)\nKHAUDEJA BANO\, Executive Medical Director\,
  Combination Product Safety Head\,Amgen (USA)\nSUMIT MUNJAL\, Vice Presid
 ent\, Global Patient Safety Evaluation\, Takeda (Belgium)\nKLAUDIJA MARIJ
 ANOVIC BARAC\, Sr Director\, Global Patient Safety &amp\; PhV\, Teva(UK)\
 nROHAN MANE\, Director\, Risk Management Product Lead\, Pfizer (UK)\nTEA 
 BABIC\, Director\, PV Audits and Inspections\,Teva Pharmaceuticals (UK)\n
 MAHESH MURTHY\,  Director of Operations - Medical Device\,Biocon\nSUBHASH
  C MANDAL\, Vice President and Chairman\, Regulatory Affairs Division\,In
 dian Pharmaceutical Association\nANIL KUKREJA\, Vice President - Medical 
 Affairs and Regulatory\,AstraZeneca\nNISHITH TYAGI\, Director (Data Scien
 ce and AI Solutions)\, Novartis\nPRAVEEN RAJ\, Senior Director Medical Af
 fairs\,Biocon\nRAJEEV SHRIVASTAVA\, Associate Director -Regulatory Affair
 s and Pharmacovigilance\,Eli Lilly\nVAIBHAV CHOUDHARY\, Associate Directo
 r Global Medical\, Clinical &amp\; Regulatory Affairs\,Fresenius Kabi\nKA
 VITA LAMROR\, Director\, Real World Investigator\,Sanofi\nKARTHIKEYAN KUM
 ARAN\, Associate Director of Information Technology\,AstraZeneca\nMILIND 
 ANTANI\, Leader\, Pharma and Healthcare\,Nishith Desai Associates\nDNYANE
 SHWAR SANAP\, EU/UK QPPV\, Head Regional Pharmacovigilance\,Glenmark (Ger
 many)\nAVINASH R. KAKADE\,SGM\, Global Head –Pharmacovigilance\, Lupin\nV
 EENA RAJAN\, Head Mature Products PV\, Global Patient Safety\,AstraZeneca
 \nJAIDEEP GOGTAY\, Chief Medical Officer\, Cipla\nGEETA SHANBHAG\,  Gener
 al Manager –Pharmacovigilance &amp\; Medico-regulatory Affairs\,Ipca Labo
 ratories\nJYOTSNA PATWARDHAN\, Cluster Head\, PV Country Quality\, Novart
 is\nJAMAL ANWAR\, Country Head Pharmacovigilance\,Merck Sharp and Dhome\n
 INDU NAMBIAR\, Head Pharmacovigilance\, Boehringer Ingelheim\nVALLABH DES
 HPANDE\, Head of Global PV Operations\, Glenmark\nVISHWAS SOVANI\, Founde
 r Director\,Pharamwisdom\nRAJENDRA KUMAR KASI\, Head - Global Pharmacovig
 ilance\,Zydus Cadila Healthcare\nROSHAN PAWAR\, Associate General Manager
 \,Alkem Laboratories\nRAGHDA MOHAMED\, PV Cluster Lead Middle East &amp\;
  Turkey\,Takeda (UAE)\nVARSHA NARAYANAN\, Founder-Director\,Dr Varsha’s H
 ealth Solutions\nSAKSHI SHRIVASTAVA DESAI\, Global Medical- PV Compliance
  Strategy and Analytics\,Johnson &amp\; Johnson\nGAYATHRI DEVI RAVICHANDR
 AN\, Associate Manager - Regional Safety Operations\,Merck\nKAVYA KADAM\,
  Consultant\, Global Clinical Trials\n\nPlus more joining soon\n\nWHO SHO
 ULD ATTEND AND WHO YOU’LL MEET:\n\nCIOs\, CEOs\, CDOs\, Vice Presidents\,
  Presidents\, Heads\, Directors and Team Leaders from the following areas
 :\n\nPharmacovigilance Strategy\, Drug Safety/Risk Management\, Informati
 on and Clinical Data Management\, Clinical Research\, Research &amp\; Dev
 elopment\, Product Safety/Assurance Assessment\, Patient Safety &amp\; Ou
 tcomes Research &amp\; Data Analysis\, Epidemiology project management\, 
 Regulatory Affairs and Compliance\, Sales &amp\; Marketing\, Biotech manu
 facturers\n\nFrom the following:\n\nPharmaceutical organizations\, Generi
 c pharmaceutical companies\, Contract research organizations\, Patient re
 cruitment companies\, Government- Department of health\, Non-profit organ
 izations/ Association\, Consultants\n\nGet more from the event\, with a b
 roader scope bringing the whole communications value chain together. Enjo
 y and make the best out of our dedicated networking time\, meet the leadi
 ng international vendors showcasing the products of tomorrow in the co-lo
 cated exhibition. Expand your knowledge of the latest business models and
  strategies in the high-level conference.\n
DTEND:20211111T170000
DTSTAMP:20260512T214301Z
DTSTART:20211111T093000
LOCATION:\,
SEQUENCE:0
SUMMARY:26TH PHARMACOVIGILANCE 2021\n“Ensuring safer drugs to market by an
 alyzing latest developments in pharmacovigilance\, drug safety and risk m
 anagement...
UID:3d924c4a-2e3a-436a-8d56-0236f821c047
END:VEVENT
END:VCALENDAR